These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8083703)

  • 21. Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group.
    Estlin EJ; Cotterill S; Pratt CB; Pearson AD; Bernstein M
    J Clin Oncol; 2000 May; 18(9):1900-5. PubMed ID: 10784630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group.
    Schnoll RA; Zhang B; Rue M; Krook JE; Spears WT; Marcus AC; Engstrom PF
    J Clin Oncol; 2003 Jan; 21(2):355-65. PubMed ID: 12525530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
    Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
    J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members.
    Helft PR; Hlubocky F; Daugherty CK
    J Clin Oncol; 2003 Mar; 21(5):942-7. PubMed ID: 12610198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
    Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
    Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. School re-entry after a cancer diagnosis: physician attitudes about truth telling and information sharing.
    Mayer DK; Parsons SK; Terrin N; Tighiouart H; Jeruss S; Nakagawa K; Iwata Y; Hara J; Saiki-Craighill S
    Child Care Health Dev; 2005 May; 31(3):355-63. PubMed ID: 15840156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitudes of CCOP physicians toward clinical trials and protocol accrual.
    Vinciguerra V; Moore T
    Prog Clin Biol Res; 1990; 339():401-7. PubMed ID: 2392432
    [No Abstract]   [Full Text] [Related]  

  • 30. Organizational barriers to physician participation in cancer clinical trials.
    Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
    Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.
    Mick R; Lane N; Daugherty C; Ratain MJ
    J Natl Cancer Inst; 1994 Nov; 86(22):1685-93. PubMed ID: 7966396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of cancer patients and their physicians involved in phase I trials.
    Daugherty C; Ratain MJ; Grochowski E; Stocking C; Kodish E; Mick R; Siegler M
    J Clin Oncol; 1995 May; 13(5):1062-72. PubMed ID: 7738612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current attitudes and practice of American Society of Clinical Oncology-member clinical oncologists regarding cancer prevention and control.
    Chlebowski RT; Sayre J; Frank-Stromborg M; Lillington LB
    J Clin Oncol; 1992 Jan; 10(1):164-8. PubMed ID: 1727917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.
    Solomon MJ; Pager CK; Young JM; Roberts R; Butow P
    Surgery; 2003 Jun; 133(6):608-13. PubMed ID: 12796726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate.
    Ellis PM; Butow PN; Tattersall MH; Dunn SM; Houssami N
    J Clin Oncol; 2001 Aug; 19(15):3554-61. PubMed ID: 11481363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers against psychosocial communication: oncologists' perceptions.
    Fagerlind H; Kettis Å; Glimelius B; Ring L
    J Clin Oncol; 2013 Oct; 31(30):3815-22. PubMed ID: 24043746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
    Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
    Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Difficult clinical decisions in gynecological oncology: identifying priorities for future clinical research.
    Harrison JD; Carter J; Young JM; Solomon MJ
    Int J Gynecol Cancer; 2006; 16(1):1-7. PubMed ID: 16445602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.